Palla Pharma Ltd
ASX:PAL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Palla Pharma Ltd
Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-13. The firm's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The firm operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The firm has developed a water-based extraction technology, which is used in NRM production. The company sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.
Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-13. The firm's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The firm operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The firm has developed a water-based extraction technology, which is used in NRM production. The company sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.
